Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
E

Failure to Monitor Adverse Drug Effects and Provide Non-Pharmacological Interventions

Seattle, Washington Survey Completed on 05-17-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that residents' drug regimens were free from unnecessary drugs by not adequately monitoring medications with known adverse side effects and not providing or documenting non-pharmacological interventions prior to administering pain medications. For one resident receiving oxycodone, there was no documentation of monitoring for adverse side effects or the use of non-pharmacological interventions before administration. The resident's pain care plan did not include opioid use, monitoring for side effects, or non-pharmacological interventions, despite staff acknowledging these should have been present. Another resident receiving insulin therapy did not have documented monitoring for hypoglycemia or hyperglycemia in the Medication Administration Record (MAR) or Treatment Administration Record (TAR), even though the care plan referenced monitoring for side effects and effectiveness. Additionally, a resident prescribed hydromorphone was not monitored for side effects, with no documentation present in the MAR or TAR. Staff interviews confirmed that monitoring for side effects and non-pharmacological interventions should have been included for these medications but were not.

An unhandled error has occurred. Reload 🗙